Rightside® to Announce First Quarter 2017 Financial Results on May 9, 2017
Apr 25, 2017 20:05 pm UTC| Business
KIRKLAND, Wash., April 25, 2017 -- Rightside Group, Ltd. (Nasdaq:NAME), a leading provider of domain name services that advance the way businesses and consumers define and present themselves online, will announce first...
Coca-Cola Bottling Co. Consolidated To Release First Quarter 2017 Results
Apr 25, 2017 20:05 pm UTC| Business
CHARLOTTE, N.C., April 25, 2017 -- Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) will issue a news release after the market closes on May 9, 2017, to announce financial results for its quarter ended April 2, 2017. ...
Sterling Bancorp Declares Quarterly Dividend of $0.07 Per Share
Apr 25, 2017 20:05 pm UTC| Business
MONTEBELLO, N.Y., April 25, 2017 -- Sterling Bancorp (NYSE:STL), the parent company of Sterling National Bank, today announced that the Board of Directors has declared a quarterly cash dividend of $0.07 per share. The...
CORRECTING and REPLACING - DNB Financial Corporation Reports First Quarter 2017 Results
Apr 25, 2017 20:03 pm UTC| Business
DOWNINGTOWN, Pa., April 25, 2017 -- This updated press release announcing results of operations for the quarter ended March 31, 2017 corrects an inadvertent error related to the Company’s non-performing assets and...
Applied Optoelectronics to Participate in Upcoming Investor Conference
Apr 25, 2017 20:03 pm UTC| Business
SUGAR LAND, Texas, April 25, 2017 -- Applied Optoelectronics, Inc. (NASDAQ:AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, fiber-to-the-home and telecom...
Apr 25, 2017 20:02 pm UTC| Business
NEW YORK, April 25, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who...
Apr 25, 2017 20:01 pm UTC| Business
Mechelen, Belgium; 25 April 2017, 22.00 CET - Galapagos NV (Euronext NASDAQ: GLPG) announces a new Phase 2 Proof-of-Concept study investigating filgotinib and another investigational agent in cutaneous lupus...